Serological markers of enterocyte damage and apoptosis in patients with celiac disease, autoimmune diabetes mellitus and diabetes mellitus type 2

Physiological Research

Volumn 64, Issue 4, 2015, Pages 537-546

  Hoffmanova I ^a   Sanchez D ^b   Habova V ^b   Andel M ^a   Tuckova L ^b   Tlaskalova Hogenova H ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Autoimmunity; Cytokeratin 18 caspase cleaved fragment; Intestinal barrier; Intestinal fatty acidbinding protein; Soluble CD14

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

ADOLESCENT; ADULT; AGED; APOPTOSIS; BLOOD; CELIAC DISEASE; COMORBIDITY; CZECH REPUBLIC; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMAN; INTESTINE CELL; LIVER DISEASES; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PREVALENCE; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BIOMARKERS; CELIAC DISEASE; COMORBIDITY; CYTOKINES; CZECH REPUBLIC; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ENTEROCYTES; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84941125804     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. ADRIAANSE MP, TACK GJ, PASSOS VL, DAMOISEAUX JG, SCHREURS MW, VAN WIJCK K, RIEDL RG, MASCLEE AA, BUURMAN WA, MULDER CJ, VREUGDENHIL AC: Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther 37: 482-490, 2013.
2. ALAVI MOGHADDAM M, ROSTAMI NEJAD M, SHALMANI HM, ROSTAMI K, NAZEMALHOSSEINI MOJARAD E, ALDULAIMI D, ZALI MR: The effects of gluten-free diet on hypertransaminasemia in patients with celiac disease. Int J Prev Med 4: 700-704, 2013.
3. ANCUTA P, KAMAT A, KUNSTMAN KJ, KIM EY, AUTISSIER P, WURCEL A, ZAMAN T, STONE D, MEFFORD M, MORGELLO S, SINGER EJ, WOLINSKY SM, GABUZDA D: Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3: e2516, 2008.
4. ASHABANI A, ABUSHOFA U, ABUSREWILL S, ABDELAZEZ M, TUCKOVÁ L, TLASKALOVÁ-HOGENOVÁ H: The prevalence of coeliac disease in Libyan children with type 1 diabetes mellitus. Diabetes Metab Res Rev 19: 69-75, 2003.
5. BAGGIO LL, DRUCKER DJ: Harnessing the therapeutic potential of glucagon-like peptide-1: a critical review. Treat Endocrinol 1: 117-125, 2002.
6. BANTEL H, RUCK P, GREGOR M, SCHULZE-OSTHOFF K: Detection of elevated caspase activation and early apoptosis in liver diseases. Eur J Cell Biol 80: 230-239, 2001.
7. BRUEWER M, UTECH M, IVANOV AI, HOPKINS AM, PARKOS CA, NUSRAT A: Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J 19: 923-933, 2005.
8. CERUTTI F, BRUNO G, CHIARELLI F, LORINI R, MESCHI F, SACCHETTI C: Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. Diabetes Care 27: 1294-1298, 2004.
9. DAMCI T, NUHOGLU I, DEVRANOGLU G, OSAR Z, DEMIR M, ILKOVA H: Increased intestinal permeability as a cause of fluctuating postprandial blood glucose levels in Type 1 diabetic patients. Eur J Clin Invest 33: 397-401, 2003.
10. DE LUIS DA, ALLER R, IZAOLA O, GONZALEZ SAGRADO M, CONDE R: Fatty acid-binding protein 2 Ala54Thr genotype is associated with insulin resistance and leptin levels changes after a high monounsaturated fat diet in obese non-diabetic patients. J Endocrinol Invest 36: 402-406, 2013.
11. DERIKX JP, MATTHIJSEN RA, DE BRUÏNE AP, VAN BIJNEN AA, HEINEMAN E, VAN DAM RM, DEJONG CH, BUURMAN WA: Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS One 3: e3428, 2008.
12. DRASTICH P, HONSOVÁ E, LODEREROVÁ A, JAREŠOVÁ M, PEKÁRIKOVÁ A, HOFFMANOVÁ I, TUČKOVÁ L, TLASKALOVÁ-HOGENOVÁ H, ŠPIČÁK J, SÁNCHEZ D: Celiac disease markers in patients with liver diseases: a single center large scale screening study. World J Gastroenterol 18: 6255-6262, 2012.
13. FASANO A, SHEA-DONOHUE T: Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol 2: 416-422, 2005.
14. FUNDA DP, TUČKOVÁ L, FARRÉ MA, IWASE T, MORO I, TLASKALOVÁ-HOGENOVÁ H: CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited. Infect Immun 69: 3772-3781, 2001.
15. GREYSTOKE A, DEAN E, SAUNDERS MP, CUMMINGS J, HUGHES A, RANSON M, DIVE C, RENEHAN AG: Multi-level evidence that circulating CK18 is a biomarker of tumor burden in colorectal cancer. Br J Cancer 107: 1518-1524, 2012.
16. HOTAMISLIGIL GS, ERBAY E: Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 8: 923-934, 2008.
17. HUMMEL S, PFLÜGER M, HUMMEL M, BONIFACIO E, ZIEGLER AG: Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care 34: 1301-1305, 2011.
18. HUSBY S, KOLETZKO S, KORPONAY-SZABÓ IR, MEARIN ML, PHILLIPS A, SHAMIR R, TRONCONE R, GIERSIEPEN K, BRANSKI D, CATASSI C, LELGEMAN M, MÄKI M, RIBES-KONINCKX C, VENTURA A, ZIMMER KP: European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 54: 136-160, 2012.
19. KNIP M, SIMELL O: Environmental triggers of Type 1 diabetes. Cold Spring Harb Perspect Med 2: a007690, 2012.
20. KNIP M, VEIJOLA R, VIRTANEN SM, HYÖTY H, VAARALA O, AKERBLOM HK: Environmental triggers and determinats of type 1 diabetes. Diabetes 54 (Suppl 2): S125-S136, 2005.
21. KRÁLOVÁ LESNÁ I, SUCHÁNEK P, BRABCOVÁ E, KOVÁŘ J, MALÍNSKÁ H, POLEDNE R: Effect of different types of dietary fatty acids on subclinical inflammation in humans. Physiol Res 62: 145-152, 2013.
22. KUČERA P, NOVÁKOVÁ D, BEHANOVÁ M, NOVÁK J, TLASKALOVÁ-HOGENOVÁ H, ANDĚL M: Gliadin, endomysial and thyroid antibodies in patients with latent autoimmune diabetes of adults (LADA). Clin Exp Immunol 133: 139-143, 2003.
23. KUO P, WISHART JM, BELLON M, SMOUT AJ, HOLLOWAY RH, FRASER RJ, HOROWITZ M, JONES KL, RAYNER CK: Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans. J Clin Endocrinol Metab 95: 3893-3900, 2010.
24. LETTRE G, RIOUX JD: Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 17: 116-121, 2008.
25. LI Q, ZHANG Q, WANG M, ZHAO S, MA J, LUO N, LI N, LI Y, XU G, LI J: Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin Immunol 126: 67-80, 2008.
26. MORLING JR, FALLOWFIELD JA, WILLIAMSON RM, NEE LD, JACKSON AP, GLANCY S, REYNOLDS RM, HAYES PC, GUHA IN, STRACHAN MW, PRICE JF: Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Liver Int 34: 1267-1277, 2014.
27. MUSSO G, GAMBINO R, CASSADER M: Obesity, diabetes, and gut microbiota: The hygiene hypothesis expanded? Diabetes Care 33: 2277-2284, 2010.
28. NOKOFF NJ, REWERS M, CREE GREEN M: The interplay of autoimmunity and insulin resistance in type 1 diabetes. Discov Med 13: 115-122, 2012.
29. OSTERBYE T, FUNDA DP, FUNDOVÁ P, MÅNSSON JE, TLASKALOVÁ-HOGENOVÁ H, BUSCHARD K: A subset of human pancreatic beta cells express functional CD14 receptors: a signaling pathway for beta cellrelated glycolipids, sulfatide and ß-galactosylceramide. Diabetes Metab Res Rev 26: 656-667, 2010.
30. PENG H, HAGOPIAN W: Environmental factors in the development of Type 1 diabetes. Rev Endocr Metab Disord 7: 149-162, 2006.
31. PHAM-SHORT A, DONAGHUE KC, AMBLER G, CHAN AK, CRAIG ME: Coeliac disease in Type 1 diabetes from 1990 to 2009: higher incidence in young children after longer diabetes duration. Diabet Med 29: e286-e289, 2012.
32. RAYNER CK, HOROWITZ M: Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited? J Clin Invest 116: 299-302, 2006.
33. REWERS M, EISENBARTH GS: Autoimmunity: Celiac disease in T1DM - the need to look long term. Nat Rev Endocrinol 8: 7-8, 2011.
34. REWERS M, LIU E, SIMMONS J, REDONDO MJ, HOFFENBERG EJ: Celiac disease associated with type 1 diabetes mellitus. Endocrinol Metab Clin North Am 33: 197-214, 2004.
35. SALARDI S, VOLTA U, ZUCCHINI S, FIORINI E, MALTONI G, VAIRA B, CICOGNANI A: Prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid-1990s: an 18-year longitudinal study based on anti-endomysial antibodies. J Pediatr Gastroenterol Nutr 46: 612-614, 2008.
36. SHAKIL A, CHURCH RJ, RAO SS: Gastrointestinal complications of diabetes. Am Fam Physician 77: 1697-1702, 2008.
37. SHALIMAR DM, DAS P, SREENIVAS V, GUPTA SD, PANDA SK, MAKHARIA GK: Mechanism of villous atrophy in celiac disease: role of apoptosis and epithelial regeneration. Arch Pathol Lab Med 137: 1262-1269, 2013.
38. SINGH P, AGNIHOTRI A, JINDAL G, SHARMA PK, SHARMA M, DAS P, GUPTA D, MAKHARIA GK: Celiac disease and chronic liver disease: is there a relationship? Indian J Gastroenterol 32: 404-408, 2013.
39. ŠTULC T, SVOBODOVÁ H, KRUPIČKOVÁ Z, DOLEŽALOVÁ R, MARINOV I, ČEŠKA R. Rosiglitazone influences the expression of leukocyte adhesion molecules and CD14 receptor in type 2 diabetes mellitus patients. Physiol Res 63 (Suppl 2): S293-S298, 2014.
40. TLASKALOVÁ-HOGENOVÁ H, ŠTĚPÁNKOVÁ R, KOZÁKOVÁ H, HUDCOVIC T, VANNUCCI L, TUČKOVÁ L, ROSSMANN P, HRNČÍŘ T, KVERKA M, ZÁKOSTELSKÁ Z, KLIMEŠOVÁ K, PŘIBYLOVÁ J, BÁRTOVÁ J, SÁNCHEZ D, FUNDOVÁ P, BOROVSKÁ D, ŠRUTKOVÁ D, ZÍDEK Z, SCHWARZER M, DRASTICH P, FUNDA DP: The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 8: 110-120, 2011.
41. TRIER JS: Celiac sprue: N Engl J Med 325: 1709-1719, 1991.
42. VAARALA O: Leaking gut in type 1 diabetes. Curr Opin Gastroenterol 24: 701-706, 2008.
43. VERDAM FJ, GREVE JW, ROOSTA S, VAN EIJK H, BOUVY N, BUURMAN WA, RENSEN SS: Small intestinal alterations in severely obese hyperglycemic subjects. J Clin Endocrinol Metab 96: e379-e383, 2011.
44. VIRALLY-MONOD M, TIELMANS D, KEVORKIAN JP, BOUHNIK Y, FLOURIE B, POROKHOV B, AJZENBERG C, WARNET A, GUILLAUSSEAU PJ: Chronic diarrhoea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth. Diabetes Metab 24: 530-536, 1998.
45. WAHAB PJ, MEIJER JW, MULDER CJ: Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol 118: 459-463, 2002.
46. WANG Y, LI J, TANG L, WANG Y, CHARNIGO R, DE VILLIERS W, ECKHARDT E: T-lymphocyte responses to intestinally absorbed antigens can contribute to adipose tissue inflammation and glucose intolerance during high fat feeding. PLoS One 5: e13951, 2010.
47. WENZLAU JM, JUHL K, YU L, MOUA O, SARKAR SA, GOTTLIEB P, REWERS M, EISENBARTH GS, JENSEN J, DAVIDSON HW, HUTTON JC: The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 104: 17040-17045, 2007.
48. WESTERHOLM-ORMIO M, VAARALA O, PIHKALA P, ILONEN J, SAVILAHTI E: Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 52: 2287-2295, 2003.
49. YAJIMA S, MORISAKI H, SERITA R, SUZUKI T, KATORI N, ASAHARA T, NOMOTO K, KOBAYASHI F, ISHIZAKA A, TAKEDA J: Tumor necrosis factor-alpha mediates hyperglycemia-augmented gut barrier dysfunction in endotoxemia. Crit Care Med 37: 1024-1030, 2009.
50. ZHAO J, FRØKJAER JB, DREWES AM, EJSKJAER N: Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus. World J Gastroenterol 12: 2846-2857, 2006.
51. ZHERNAKOVA A, WITHOFF S, WIJMENGA C: Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat Rev Endocrinol 9: 646-659, 2013.